R
  • 773.714.0705
  • Home
  • About Us
  • Therapeutic Area
  • Activities
    • Live
    • Online
  • Outcomes & Toolkits
New User? Login
Certificate Use Certificate Code
Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer
Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer
Expert Perspectives

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer. Faculty provide practical guidance to apply available and emerging data in real-world decision-making that clinicians are faced with on a daily basis including: interpreting results to inform treatment decisions, biomarker testing, patient selection, and combination therapy. Video modules are also available as downloadable audio podcasts and transcripts.

Faculty: Neeraj Agarwal, MD; Celestia Higano, MD, FACP; Daniel Petrylak, MD; Patrick G. Pilié, MD; Neal Shore, MD, FACS

Release Date: April 05, 2021

Expiration Date: July 08, 2022

CME/CE is no longer available for this activity

footer-logo

230 W. Monroe Street
Suite 2300
Chicago, IL 60606

  • Phone: 773.714.0705
  • Fax: 773.714.0707
  • Home
  • Therapeutic Areas
  • Sitemap
  • Privacy Policy
  • Contact Us
  • Follow us on Twitter
  • Like us on Facebook
  • Follow us on LinkedIn

Copyright © 2023 Academy for Continued Healthcare Learning. All Rights Reserved.

Processing...
×